Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1100 (LINC01100) is a human gene that produces a long non-coding RNA (lncRNA), annotated as a non-protein-coding transcript. LINC01100 is located on chromosome 3 (3q25.31 region), and its transcript shows no protein coding potential. It is referenced in gene resources such as NCBI (Gene ID: 730109), Ensembl (ENSG00000242107), and GeneCards. LINC01100 is not recognized as a therapeutic target, and there is currently no strong evidence for its involvement in human disease, nor are there known interactions with drugs or evidence that it serves as a biomarker. This distinguishes LINC01100 from other lncRNAs that have characterized roles in cancers and other diseases[1][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1100 (LINC01100).